Advances in genomic medicine indicate that pediatric cancers may be quite different from their adult counterparts. Hear from experts on why this might be and what scientists are doing to understand it better.

Many pediatric cancers do not harbor the same targetable mutations seen in adult tumors, making it imperative that we understand the reasons behind these differences. Following up on the 2016 Sohn Conference, "Pediatric Cancer in a Post-genomic World," presented by The Sohn Conference Foundation and the New York Academy of Sciences, this podcast gives listeners a glimpse into where research and treatment are today and where they are headed in the future.